MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iacovelli, L.
Right arrow Articles by De Blasi, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iacovelli, L.
Right arrow Articles by De Blasi, A.

Vol. 56, Issue 2, 316-324, August 1999

Selective Regulation of G Protein-Coupled Receptor-Mediated Signaling by G Protein-Coupled Receptor Kinase 2 in FRTL-5 Cells: Analysis of Thyrotropin, alpha 1B-Adrenergic, and A1 Adenosine Receptor-Mediated Responses

Luisa Iacovelli, Rossana Franchetti, Deborah Grisolia, and Antonio De Blasi

Consorzio Mario Negri Sud, Istituto di Ricerche Farmacologiche "Mario Negri," Santa Maria Imbaro, Italy

G protein-coupled receptor kinases (GRKs) play a key role in the process of receptor homologous desensitization. In the present study, we address the question of whether a variety of receptors coupled to different G protein subtypes and naturally expressed on the same cell are selectively regulated by GRK2. The signaling stimulated by thyrotropin (TSH), alpha 1B-adrenergic, and A1 adenosine receptors was studied in FRTL-5 cells permanently transfected to overexpress GRK2 and GRK2-K220R, a kinase dead GRK dominant negative mutant. In FRTL-5 overexpressing GRK2, TSH-induced cyclic AMP response was attenuated, indicating that TSH receptor is desensitized by this kinase. Consistently, FRTL-5 cells overexpressing GRK2-K220R show increased TSH-induced cyclic AMP response, demonstrating that this receptor is under tonic control by GRK. Unlike TSH receptor, alpha 1B-adrenergic receptor response was unaffected in FRTL-5 overexpressing GRK2 and GRK2-K220R. When A1 adenosine receptors were stimulated, Gialpha -mediated cyclic AMP inhibition was totally unaffected by overexpression of either GRK2 or GRK2-K220R. By contrast, Gbeta gamma -mediated response (activation of mitogen-activated protein kinases) was efficiently desensitized by GRK2 but was unaffected by GRK2-K220R overexpression. The present study documents that overexpression of GRK2 results in a selective regulation of different G protein-coupled receptors expressed on the same cell and that this kinase can regulate preferentially only one of the different pathways activated by the same receptor. The preferential regulation of the A1 adenosine receptor-stimulated mitogen-activated protein kinases by GRK2 indicates that this kinase can have additional regulatory effects on Gbeta gamma -stimulated pathways, possibly through direct binding and regulation of the receptor-Gbeta gamma complex.


Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
L. Iacovelli, G. Molinaro, G. Battaglia, M. Motolese, L. Di Menna, M. Alfiero, J. Blahos, F. Matrisciano, M. Corsi, C. Corti, et al.
Regulation of Group II Metabotropic Glutamate Receptors by G Protein-Coupled Receptor Kinases: mGlu2 Receptors Are Resistant to Homologous Desensitization
Mol. Pharmacol., April 1, 2009; 75(4): 991 - 1003.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
T. Metaye, P. Levillain, J.-L. Kraimps, and R. Perdrisot
Immunohistochemical detection, regulation and antiproliferative function of G-protein-coupled receptor kinase 2 in thyroid carcinomas
J. Endocrinol., July 1, 2008; 198(1): 101 - 110.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. Zhou, M. F. A. Livak, M. Bernier, D. C. Muller, O. D. Carlson, D. Elahi, S. Maudsley, and J. M. Egan
Ubiquitination is involved in glucose-mediated downregulation of GIP receptors in islets
Am J Physiol Endocrinol Metab, August 1, 2007; 293(2): E538 - E547.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
T. Molina-Munoz, M. T. Romero-Avila, and J. A. Garcia-Sainz
Insulin-Like Growth Factor-I Induces {alpha}1B-Adrenergic Receptor Phosphorylation through Gss{gamma} and Epidermal Growth Factor Receptor Transactivation
Mol. Endocrinol., November 1, 2006; 20(11): 2773 - 2783.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. Gros, Q. Ding, J. Chorazyczewski, J. Andrews, J. G. Pickering, R. A. Hegele, and R. D. Feldman
The Impact of Blunted beta-Adrenergic Responsiveness on Growth Regulatory Pathways in Hypertension
Mol. Pharmacol., January 1, 2006; 69(1): 317 - 327.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L. Iacovelli, L. Capobianco, M. Iula, V. Di Giorgi Gerevini, A. Picascia, J. Blahos, D. Melchiorri, F. Nicoletti, and A. De Blasi
Regulation of mGlu4 Metabotropic Glutamate Receptor Signaling by Type-2 G-Protein Coupled Receptor Kinase (GRK2)
Mol. Pharmacol., May 1, 2004; 65(5): 1103 - 1110.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Metaye, E. Menet, J. Guilhot, and J.-L. Kraimps
Expression and Activity of G Protein-Coupled Receptor Kinases in Differentiated Thyroid Carcinoma
J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3279 - 3286.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. D. Eckhart and W. J. Koch
Transgenic Studies of Cardiac Adrenergic Receptor Regulation
J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 1 - 5.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
F. M. Dautzenberg, S. Braun, and R. L. Hauger
GRK3 mediates desensitization of CRF1 receptors: a potential mechanism regulating stress adaptation
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2001; 280(4): R935 - R946.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. SALLESE, L. SALVATORE, E. D’URBANO, G. SALA, M. STORTO, T. LAUNEY, F. NICOLETTI, T. KNÖPFEL, and A. DE BLASI
The G-protein-coupled receptor kinase GRK4 mediates homologous desensitization of metabotropic glutamate receptor 1
FASEB J, December 1, 2000; 14(15): 2569 - 2580.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
M. Sallese, S. Mariggiò, E. D'Urbano, L. Iacovelli, and A. De Blasi
Selective Regulation of Gq Signaling by G Protein-Coupled Receptor Kinase 2: Direct Interaction of Kinase N Terminus with Activated Galpha q
Mol. Pharmacol., April 1, 2000; 57(4): 826 - 831.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
A. D. Eckhart, S. J. Duncan, R. B. Penn, J. L. Benovic, R. J. Lefkowitz, and W. J. Koch
Hybrid Transgenic Mice Reveal In Vivo Specificity of G Protein-Coupled Receptor Kinases in the Heart
Circ. Res., January 7, 2000; 86(1): 43 - 50.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Horie and P. A. Insel
Retrovirally Mediated Transfer of a G Protein-coupled Receptor Kinase (GRK) Dominant-negative Mutant Enhances Endogenous Calcitonin Receptor Signaling in Chinese Hamster Ovary Cells. GRK INHIBITION ENHANCES EXPRESSION OF RECEPTORS AND RECEPTOR mRNA
J. Biol. Chem., September 15, 2000; 275(38): 29433 - 29440.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics